Efficacy and Safety of Everolimus with Reduced Tacrolimus in Living-Donor Liver Transplant (LDLT) Recipients with Hepatocellular Carcinoma: Subgroup Analysis from the H2307 Study

被引：0
|
作者：
Jeng, L. -B. [1 ]
Lee, S. -G. [2 ]
Lee, W. -C. [3 ]
Suh, K. -S. [4 ]
Joo, D. J. [5 ]
Joh, J. [6 ]
Kaido, T. [7 ]
Lopez, P. [8 ]
Kochuparampil, J. [8 ]
Kaneko, S. [9 ]
Levy, G. [10 ]
机构：
[1] China Med Univ Hosp, Taichung, Taiwan
[2] Asan Med Ctr, Seoul, South Korea
[3] Chang Gung Mem Hosp, Taoyuan, Taiwan
[4] Seoul Natl Univ Hosp, Seoul, South Korea
[5] Yonsei Univ, Coll Med, Severance Hosp, Seoul, South Korea
[6] Samsung Med Ctr, Seoul, South Korea
[7] Kyoto Univ Hosp, Kyoto, Japan
[8] Novartis Pharma AG, Basel, Switzerland
[9] Novartis Pharma KK, Tokyo, Japan
[10] Univ Toronto, Toronto, ON, Canada
来源：
TRANSPLANTATION | 2017年 / 101卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
LB P-19
引用
收藏
页码：375 / 376
页数：2
相关论文
共 50 条
  • [41] Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of 2 Randomized Controlled Trials
    Lee, Sung-Gyu
    Jeng, Long-Bin
    Saliba, Faouzi
    Soin, Arvinder Singh
    Lee, Wei-Chen
    De Simone, Paolo
    Nevens, Frederik
    Suh, Kyung-Suk
    Fischer, Lutz
    Joo, Dong Jin
    Fung, John
    Joh, Jae-Won
    Kaido, Toshimi
    Grant, David
    Meier, Matthias
    Rauer, Barbara
    Sips, Carole
    Kaneko, Shuhei
    Levy, Gary
    TRANSPLANTATION, 2021, 105 (07) : 1564 - 1575
  • [42] Design and Baseline Data from Hephaistos Study Evaluating Efficacy and Safety of Early Initiation of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients
    Nashan, Bjorn
    Schemmer, Peter
    Braun, Felix
    Dworak, Markus
    Wimmer, Peter
    Schlitt, Hans
    TRANSPLANTATION, 2015, 99 : 214 - 215
  • [43] Efficacy and Safety of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients: Long-Term Results From the H2304E1 Study.
    Duvoux, C.
    Saliba, F.
    Kaiser, G.
    De Carlis, L.
    Metselaar, H.
    De Simone, P.
    Nevens, F.
    Fischer, L.
    Fung, J.
    Dong, G.
    Rauer, B.
    Junge, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 710 - 710
  • [44] Efficacy and Safety of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients: Long-Term Results From the H2304E1 Study.
    Duvoux, C.
    Saliba, F.
    Kaiser, G.
    De Carlis, L.
    Metselaar, H.
    De Simone, P.
    Nevens, F.
    Fischer, L.
    Fung, J.
    Dong, G.
    Rauer, B.
    Junge, G.
    TRANSPLANTATION, 2014, 98 : 710 - 710
  • [45] SAFETY AND EFFICACY OF EARLY USE OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS VS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA
    Schlitt, H. J.
    Nashan, B.
    Schemmer, P.
    Pascher, A.
    Klein, C. G.
    Neumann, U.
    Kroeger, I.
    Wimmer, P.
    Braun, F.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 25 - 25
  • [46] HEPHAISTOS study: Early use of everolimus plus reduced tacrolimus in de novo liver transplant recipients achieves high efficacy and safety compared to standard tacrolimus.
    Schemmer, P.
    Nashan, B.
    Braun, F.
    Pascher, A.
    Klein, C. -G
    Neumann, U.
    Kroeger, I
    Wimmer, P.
    Schlitt, H. J.
    TRANSPLANTATION, 2019, 103 (08) : 298 - 298
  • [47] A comparison of adult living donor (LDLT) to deceased donor liver transplant (DDLT) for hepatocellular carcinoma (HCC): Data from the A2ALL study
    Kulik, LM
    Freise, CE
    Lok, AS
    Stravitz, RT
    Hulbert-Shearon, TE
    Fisher, RA
    HEPATOLOGY, 2005, 42 (04) : 199A - 200A
  • [48] Quality of Life and Psychologic Distress of Recipients after Adult Living-Donor Liver Transplantation (LDLT)-A Study from Mainland China
    Jin, S.
    Yan, L.
    Li, B.
    Wen, T.
    Zhao, J.
    Zeng, Y.
    Chen, Z.
    Wang, W.
    Xu, M.
    Yang, J.
    Luo, Y.
    Wu, H.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (07) : 2611 - 2616
  • [49] EFFECT OF EVEROLIMUS WITH REDUCED TACROLIMUS ON RENAL FUNCTION (RF) AFTER LIVING-DONOR LIVER TRANSPLANTATION (LDLT): 12-MONTH RESULTS FROM AN INTERNATIONAL RANDOMIZED TRIAL (NCT01888432)
    Braun, F.
    Settmacher, U.
    Lopez, P. M.
    Sips, C.
    Lieb, S.
    TRANSPLANT INTERNATIONAL, 2017, 30 : 26 - 26
  • [50] A Pilot Study of the Pharmacokinetics of the Modified-Release Once-Daily Tacrolimus Formulation Administered to Living-Donor Liver Transplant Recipients
    Song, Gi-Won
    Lee, Sung-Gyu
    Hwang, Shin
    Kim, Ki-Hum
    Kim, Wan-Joon
    Sin, Min-Ho
    Yoon, Young-In
    Tak, Eun-Young
    Experimental and Clinical Transplantation, 2016, 14 (04) : 412 - 418
12345